Fibrocystic Disease
Mostrando 1-12 de 13 artigos, teses e dissertações.
-
1. Avaliação da presença do polimorfismo Msp1 da CYP1A1 do citocromo P-450 em mulheres assintomáticas portadoras de cisto mamário. / Evaluation of the presence of Msp1 polymorphism of cytochrome P-450 CYP1A1 in asymptomatic women suffering from breast cyst
Objetivo: o objetivo do estudo foi verificar a prevalência da alteração fibrocística da mama, na sua forma cística, dentre as diversas faixas etárias da população feminina e correlacionar a doença cística com a presença do polimorfismo Msp1 da CYP1A1 do citocromo P450 . Casuística e métodos: Estudo retrospectivo, caso-controle, desenvolvido entr
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 02/12/2010
-
2. Analise dos alelos S e Z da alfa 1 antitripsina em uma amostra de pacientes fibrocisticos
Cystic fibrosis is a genetic disorder that during its course presents mainly pulmonary and pancreatic manifestations. Its genotype-phenotype correlation has motivated many arduous studies. The only correlation so far encountered is with pancreatic insufficiency. It has also been noted that the course of the disease as well as the severity of its pulmonary ma
Publicado em: 2002
-
3. Cigarette smoking and benign breast disease.
The association between cigarette smoking and the occurrence of benign breast disease was assessed in a hospital-based case-control study conducted in Connecticut during 1979-81. Current smokers, but not former smokers, were at reduced risk for all benign breast diseases. The odds ratios associated with current smoking were 0.7 (95% confidence intervals = 0.
-
4. Fibrocystic Disease of the Pancreas
-
5. Elmslie and Fibrocystic Disease of Bone
-
6. GLAUCOMA SECONDARY TO FIBROCYSTIC DISEASE OF BONE
-
7. FIBROCYSTIC DISEASE OF THE FRONTAL BONE (PAGET'S OSTEITIS)
-
8. The Sweat Test in the Diagnosis of Fibrocystic Disease of the Pancreas
-
9. Vimentin expression in benign and malignant breast epithelium.
AIMS--To determine vimentin expression in epithelial cells in benign breast disease and malignant breast tumours; to assess the value of vimentin expression as a prognostic indicator in breast carcinoma. METHODS--Frozen and formalin fixed, paraffin wax embedded sections from 78 carcinomas, three phyllodes tumours, 19 fibroadenomas and 19 cases of fibrocystic
-
10. Cytokeratin intermediate filament expression in benign and malignant breast disease.
AIM--To carry out a comprehensive study of cytokeratin expression in benign and malignant breast epithelium and breast myoepithelial cells; to examine changes in the cytokeratin profile in malignant and benign epithelium and in carcinomas of increasing histological grade. METHODS--Frozen sections from fibroadenomas (19 cases), fibrocystic disease (19 cases),
-
11. Hyperexpression of mitogen-activated protein kinase in human breast cancer.
Mitogen-activated protein (MAP) kinases act as transducers of extracellular signaling via tyrosine kinase-growth factor receptors and G-protein-linked receptors to elements regulating transcription. The activity, abundance, and localization of MAP kinase was investigated in normal and malignant neoplasia of the breast. In carcinoma of the breast, MAP kinase
-
12. Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas.
Monoclonal antibodies (MAbs) of predefined specificity have been generated by utilizing a synthetic peptide reflecting amino acid positions 10-17 of the Hu-rasT24 gene product as immunogen. These MAbs, designated RAP-1 through RAP-5 (RA, ras; P, peptide), have been shown to react with the ras gene product p21. Since the Hu-ras reactive determinants (position